Guanethidine sympathectomy increases substance P concentration in the superior sympathetic ganglion of adult rats.
Adult rats received intraperitoneal injections of guanethidine or saline for 5 weeks. Six to 8 weeks following completion of treatment, concentrations of substance P and neuropeptide Y (NPY) were measured by radioimmunoassay in the superior cervical ganglion (SCG) and thoracic spinal cord. The SCG was also immunostained for NPY and substance P. No differences were observed in thoracic spinal cord content of either NPY or substance P. We observed depletion of NPY immunoreactive neurons and NPY levels in the SCG, and pharmacologic evidence of postganglionic denervation in guanethidine-treated rats. In guanethidine-treated rats, there was a marked increase of substance P levels in the SCG, where substance P was localized in fibers, but not cell bodies. Thus, sprouting of substance P-containing sensory fibers in the sympathetic ganglia occurs following postganglionic sympathectomy in adult rats.
Benarroch
E E
EE
Department of Neurology, Mayo Clinic, Rochester, MN 55905.
Zollman
P J
PJ
Schmelzer
J D
JD
Nelson
D K
DK
Low
P A
PA
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D005728:Ganglia, Sympathetic / Q000378:metabolism*; D006145:Guanethidine; D006339:Heart Rate / Q000187:drug effects; D007150:Immunohistochemistry; D008297:Male; D009412:Nerve Fibers / Q000187:drug effects / Q000378:metabolism; D009478:Neuropeptide Y / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism; D013373:Substance P / Q000378:metabolism*; D013563:Sympathectomy, Chemical
D009478:Neuropeptide Y; D013373:Substance P; D006145:Guanethidine